Aspen Pharmacare reported ZAR5.37B in Selling and Administration Expenses for its fiscal semester ending in December of 2024.


Selling And Administration Expenses Change Date
Adcock Ingram Holdings ZAR 1.05B 50.17M Dec/2024
Aspen Pharmacare ZAR 5.37B 230M Dec/2024
Cipla INR 13.12B 792M Jun/2025
Dr.Reddys Laboratories INR 25.65B 10.39B Jun/2025
Jiangsu Hengrui CNY 3.12B 575.34M Jun/2025
Kalbe Farma IDR 2.1T 312.21B Jun/2025
Life Healthcare 197M 76M Sep/2024
Netcare ZAR 5.01B 380M Sep/2024
Richter Gedeon HUF 51.12B 4.36B Sep/2024